bpc 157 human clinical trial osteoarthritis Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions BPC-157 Peptide Therapy: What the

That is all it takes

A subsequent 2014 paper by Chang and colleagues in Molecules showed that BPC-157, applied at 0.10.5 g/mL in vitro, dose- and time-dependently upregulated growth hormone receptor expression at both mRNA and protein levels in cultured rat Achilles tendon fibroblasts a mechanistic in vitro finding for which numeric fold-changes and p-values are not reported in the abstract

Most studies are preclinical, conducted on animals rather than humans, and there is no large-scale clinical trial proving the full extent of these benefits

Use is restricted to trained professionals in appropriate scientific environments.